Pure Global
NCT04610762

HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels

Using the Cepheid GeneXpert HCV VL Fingerstick Test as a Diagnostic Tool for Chronic Hepatitis C Among Drug Users in Brussels
Centre Hospitalier Universitaire Saint Pierre·ClinicalTrials.gov·diagnostic testNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hepatitis C, Chronic
Drug/Device/Intervention
GeneXpert HCV VL Fingerstick test
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Centre Hospitalier Universitaire Saint Pierre
Location
Bruxelles, Belgium
Timeline & enrollment
Phase
N/A
Start date
Nov 17, 2020
End date
Dec 01, 2022
Enrollment
300 participants
Primary outcome

Evaluation of interest and impact of this new method by the number of participants tested in outreach approaches

Summary

The main objective of this study is to assess the interest (linkage to care) of the Cepheid
 GeneXpert HCV VL Fingerstick test in Brussels among drug users or former users in contact
 with the Réseau Hépatite C Bruxelles organization through different partners of this network.

ICD-10 classifications
Chronic viral hepatitis CAcute hepatitis CChronic hepatitis, unspecifiedChronic viral hepatitisChronic viral hepatitis, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04610762
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04610762 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Universitaire Saint Pierre and is currently Not yet recruiting. The study focuses on Hepatitis C, Chronic. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.